| Pharmaceutical active ingredients: |
| Methylprednisolone |
| Available forms, composition and doses of Promacortine: |
| N / A |
| Promacortine medical category: |
| Human:AdrenalsAnti-inflammatory agentsCorticosteroid hormonesEye corticosteroidsOestrogens and progesterones and related synthetic drugsTopical corticosteroidsTreatment of dermatological diseasesWeak (group I) corticosteroids |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D07AA01 - MethylprednisoloneD10AA02 - MethylprednisoloneH02AB04 - Methylprednisolone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Proloxin | Mephenesin | Unidentified Pharmaceutical Company |
| Proluteasi | Norethindrone | Unidentified Pharmaceutical Company |
| Prolutin | Progesterone | Unidentified Pharmaceutical Company |
| Prolutol | Ethisterone | Unidentified Pharmaceutical Company |
| Proluton C | Ethisterone | Unidentified Pharmaceutical Company |
| Promacot | Promethazine Hydrochloride | Unidentified Pharmaceutical Company |
| Promar | Diphenadione | Unidentified Pharmaceutical Company |
| Promar PCQ | Diphenadione | Unidentified Pharmaceutical Company |
| Promato | Meprobamate | Unidentified Pharmaceutical Company |
| Promazil | Promazine | Unidentified Pharmaceutical Company |